article thumbnail

Petrie-Flom Welcomes 2022-2023 Student Fellows

Bill Of Health

These five students are a fantastic cohort of health law policy, biotechnology, and bioethics scholars who join us from across Harvard. After graduating from law school, she has trained at Hogan Lovells in their Milan office, specializing in pharmaceutical patent litigation. Louis (USA). Katie Gu is a law student (JD 2024).

article thumbnail

Governing Health Data for Research, Development, and Innovation: The Missteps of the European Health Data Space Proposal

Bill Of Health

Is research in the interest of the public domain an activity exclusively developed by academic or healthcare entities, or can it be carried out by industry (pharmaceutical, biotechnology, technology companies, medical technology industries, and insurance providers)? If so, how?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Reclaiming Global Public Health

Bill Of Health

Dose shortages elevated the role of pharmaceutical executives. Pharmaceutical corporations hoarded technology that could have helped alleviate scarcity. At the end of 2021, Thomas Cueni, the head of an international pharmaceutical trade association, acknowledged that everyone was “ashamed and embarrassed” by the inequity. “We

article thumbnail

Access-to-Medicines Activists Demand Health Justice During COVID-19 Pandemic

Bill Of Health

Activists anticipated the rise of vaccine, therapeutic, and testing nationalism — with rich countries securing preferential access to COVID-19 medical technologies and preventing export to other countries even before they had been approved — and the press soon followed.